Medline Inc. (NASDAQ:MDLN) is one of the
The 10 Best New Stocks to Invest in According to Hedge Funds.
Medline Inc. (NASDAQ:MDLN) is one of the best new stocks to invest in according to hedge funds. On April 16, Medline announced an agreement with Symbotic to implement AI-powered warehouse automation, making it the first healthcare company to use this technology. The partnership involves the deployment of Symbotic System, an artificial intelligence platform that uses autonomous robots to manage product picking, storage and retrieval.
Medline plans to pilot this technology in 2027 at one of its 45 US distribution centers to improve the resiliency and scalability of the healthcare supply chain. The system is designed to automate the process of depalletizing incoming goods, storing items, and building smart outbound pallets tailored to the specific layouts of subsequent recipients.
This level of automation aims to drive faster, more efficient operations while improving order accuracy. By integrating these robotics, Medline Inc. (NASDAQ:MDLN) aims to better support its vertically integrated model of manufacturing and distribution of medical-surgical products across all points of care. This collaboration builds on Medline’s broader commitment to modernize its fulfillment network through advanced technologies such as robotic product-to-person systems and proprietary packaging tools.
Medline Inc. (NASDAQ:MDLN) is a medical supplies and instruments company serving hospitals, post-acute care facilities and nursing homes through two segments: Medline Brand and Supply Chain Solutions.
While we recognize MDLN’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.
READ NEXT: 33 stocks that should double in 3 years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.